The role of heme in gene expression

International Journal of Hematology

Volumn 63, Issue 3, 1996, Pages 167-178

  Sassa, Shigeru ^a   Nagai, Tadashi ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Gene expression; Heme; Tissue specific regulation; Aminolevulinate synthase

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; HEME; ISOENZYME;

GENE EXPRESSION; HEME SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY;

EID: 0029960838     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00449-5     Document Type: Review

References (71)

1. Granick S. The induction in vitro of the synthesis of δ-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem 1966; 241:1359-1375.
2. Bishop DF, Henderson AS, Astrin KH. Human δ-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics 1990;7:207-214.
3. Granick S, Urata G. Increase in activity of δ-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biol Chem 1963;238:821-827.
4. Sassa S, Granick S. Induction of δ-aminolevulinic acid synthetase in chick embryo liver cells in cluture. Proc Natl Acad Sci USA 1970;67:517-522.
5. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). The Metabolic and Molecular Basis of Inherited Disease, 7th Edn. New York: McGraw-Hill, 1995;2103-2159.
6. Wada O, Yano Y, Urata G, Nakao K. Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem Pharmacol 1968;17:595-603.
7. Sassa S, Kappas A. Genetic, metabolic, and biochemical aspects of the porphyrias. In: Harris H, Hirschhorn K, (eds). Advances in Human Genetics. New York: Plenum, 1981;121-231.
8. Granick S, Sassa S. δ-Aminolevulinic acid synthetase and the control of heme and chlorophyll synthesis. In: Vogel HJ, (ed). Metabolic Regulation. New York: Academic, 1971;77-141.
9. Nagai M, Fujita H, Nagai T, Yamamoto M, Goto K, Kondo H, Hayashi N, Sassa S. Distinctive regulation of heme synthesis in the rat Harderian gland. 1996, in press.
10. Dominguez P, Antolin I, Boga JA, Uria H, Menendezpelaez A. Androgen regulation of gene expression in the Syrian hamster Harderian gland. Mol Cell Endocrinol 1994;106:81-89.
11. Granick S, Sinclair P, Sassa S, Grieninger G. Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem 1975; 250:9215-9225.
12. Tyrrell DL, Marks GS. Drug-induced porphyrin biosynthesis. V. Effect of protohemin on the transcriptional and post-transcriptional phases of δ-aminolevulinic acid synthetase induction. Biochem Pharmacol 1972;21: 2077-2093.
13. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Alcedo JA, Wetterhahn KE. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys 1991;289:387-392.
14. Hayashi N, Terasawa M, Yamauchi K, Kikuchi G. Effects of hemin on the synthesis and intracellular translocation of δ-aminolevulinate synthase in the liver of rats treated with 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biochem (Tokyo) 1980;88:1537-1543.
15. Scholnick PL, Hammaker LE, Marver HS. Soluble δ-aminolevulinic acid synthetase of rat liver. II. Studies related to the mechanism of enzyme action and hemin inhibition. J Biol Chem 1972;247:4132-4137.
16. Tschudy DP, Hess RA, Frykholm BD. Inhibition of δ-aminolevulinic acid dehydratase by 4,6-dioxoheptanoic acid. J Biol Chem 1981;256:9915-9923.
17. Sassa S, Kappas A. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of δ-aminolevulinic acid dehydratase activity by succinylacetone. J Clin Invest 1983;71:625-634.
18. Yannoni CZ, Robinson SH. Early-labeled haem in erythroid and hepatic cells. Nature 1975;258:330-331.
19. Grandchamp B, Bissell DM, Licko V, Schmid R. Formation and disposition of newly synthesized heme in adult rat hepatocytes in primary culture. J Biol Chem 1981;256:11 677-11 683.
20. Badawy AA. Central role of tryptophan pyrrolase in haem metabolism. Biochem Soc Trans 1979;7:575-583.
21. Tenhunen R, Marver HS, Schmid R. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med 1970;75:410-425.
22. De Matteis F, Gibbs AH, Unseld A. Loss of haem from cytochrome P-450 caused by lipid peroxidation and 2-allyl-2-isoprophylacetamide. An abnormal pathway not involving production of carbon monoxide. Biochem J 1977;168:417-422.
23. Rifkind AB. Maintenance of microsomal hemoprotein concentrations following inhibition of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydrocollidine in chick embryo liver. J Biol Chem 1979;254:4636-4644.
24. Anderson KE. Effects of antihypertensive drugs on hepatic heme biosynthesis, and evaluation of ferrochelatase inhibitors to simplify testing of drugs for heme pathway induction. Biochim Biophys Acta 1978;543:313-327.
25. Sinclair P, Granick S. Heme control on the synthesis of δ-aminolevulinic acid synthetase in cultured chick embryo liver cells. Ann NY Acad Sci 1975;244:509-518.
26. Sassa S, Kappas A. Induction of δ-aminolevulinate synthase and porphyrins in cultured liver cells maintained in chemically defined medium. Permissive effects of hormones on induction process. J Biol Chem 1977;252: 2428-2436.
27. Shibahara S. Regulation of heme oxygenase gene expression. Semin Hematol 1988;25:370-376.
28. Maines MD, Kappas A. Metals as regulators of heme metabolism. Science 1977;198:1215-1221.
29. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988;2:2557-2568.
30. Levin W, Sernatinger E, Jacobson M, Kuntzman R. Destruction of cytochrome P 450 by secobarbital and other barbiturates containing allyl groups. Science 1972;176: 1341-1343.
31. Rosenberg DW, Drummond GS, Cornish HC, Kappas A. Prolonged induction of hepatic haem oxygenase and decreases in cytochrome P-450 content by organotin compounds. Biochem J 1980; 190:465-468.
32. Galbraith RA, Drummond GS, Kappas A. Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications. J Clin Invest 1985;76:2436-2439.
33. Shirama K, Furuya T, Takeo Y, Shimizu K, Maekawa K. Influences of some endocrine glands and of hormone replacement on the porphyrins of the Harderian glands of mice. J Endocrinol 1981;91:305-311.
34. Payne AP, McGadey J, Moore MR, Thompson GG. Changes in Harderian gland activity in the female Golden Hamster during the oestrous cycle, pregnancy and lactation. Biochem J 1979;178:597-604.
35. Eida K, Kubota N, Nishigaki T, Kikutani M. Harderian gland. V. Effect of dietary pantothenic acid deficiency on porphyrin biosynthesis in Harderian gland of rats. Chem Pharmacol Bull 1975;23:1-4.
36. Margolis FL. Regulation of porphyrin biosynthesis in the Harderian gland of inbred mouse strains. Arch Biochem Biophys 1971;145:373-381.
37. Moore MR, Thompson GG, Payne AP, McGadey J. Seasonal variation in delta-aminolaevulinate synthase and porphyrin content in the Harderian gland of the female golden hamster (Mesocricetus auratus). Int J Biochem 1980;12:501-504.
38. Tomio JM, Grinstein M. Porphyrin biosynthesis. 5. Biosynthesis of protoporphyrin IX in Harderian glands. Eur J Biochem 1968;6:80-83.
39. Spike RC, Johnston HS, McGadey J, Moore MR, Thompson GG, Payne AP. Quantitative studies on the effects of hormones on structure and porphyrin biosynthesis in the harderian gland of the female golden hamster. II. The time course of changes after ovariectomy. J Anat 1986;145:67-77.
40. Spike RC, Payne AP, Moore MR. The effects of age on the structure and porphyrin synthesis of the harderian gland of the female golden hamster. J Anat 1988;160:157-166.
41. Marks PA, Rifkind RA. Erythroleukemic differentiation. Annu Rev Biochem 1978;47:419-448.
42. Ross J, Sautner D. Induction of globin mRNA accumulation by hemin in cultured erythroleukemic cells. Cell 1976;8:513-520.
43. Dabney BJ, Beaudet AL. Increase in globin chains and globin mRNA in erythroleukemia cells in response to hemin. Arch Biochem Biophys 1977;179:106-112.
44. Granick JL, Sassa S. Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture. J Biol Chem 1978;253:5402-5406.
45. Fukuda Y, Fujita H, Garbaczewski L, Sassa S. Regulation of β-globin mRNA accumulation by heme in DMSO-sensitive and DMSO-resistant murine erythroleukemia cells. Blood 1994;83:1662-1667.
46. Beaumont C, Deybach JC, Grandchamp B, Da Silva V, de Verneuil H, Nordmann Y. Effects of succinylacetone on dimethylsulfoxide-mediated induction of heme pathway enzymes in mouse friend virus-transformed erythroleukemia cells. Exp Cell Res 1984;154:474-484.
47. Fujita H, Yamamoto M, Yamagami T, Hayashi N, Sassa S. Erythroleukemia differentiation. Distinctive responses of the erythroid-specific and the nonspecific δ-aminolevulinate synthase mRNA. J Biol Chem 1991;266: 17 494-17 502.
48. Melefors O, Goossen B, Johansson HE, Stripecke R, Gray NK, Hentze MW. Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells. J Biol Chem 1993;268: 5974-5978.
49. Fukuda Y, Fujita H, Taketani S, Sassa S. Haem is necessary for a continued increase in ferrochelatase mRNA in murine erythroleukaemia cells during erythroid differentiation. Br J Haematol 1993;85:670-675.
50. Meguro K, Igarashi K, Yamamoto M, Fujita H, Sassa S. The role of the erythroid-sepcific delta-aminolevulinate symthase gene expression in erythroid heme synthesis. Blood 1995;86:940-948.
51. Charnay P, Maniatis T. Transcriptional regulation of globin gene expression in the human erythroid cell line K562. Science 1983;220:1281-1283.
52. Papayannopoulou T, Nakamoto B, Kurachi S, Nelson R. Analysis of the erythroid phenotype of HEL cells: clonal variation and the effect of inducers. Blood 1987;70:1764-1772.
53. Papayannopoulou T, Nakamoto B, Kurachi S, Tweeddale M, Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 1988;72: 1029-1038.
54. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989;140: 323-334.
55. Endo T, Ishibashi Y, Shiokawa S, Fukumaki Y, Okano H. Differential induction of adult and fetal globin gene expression in the human CML cell subline KU-812F/33. J Biochem (Tokyo) 1994;115:540-544.
56. Endo K., Harigae H, Nagai T, Fujie H, Meguro K, Watanabe N, Furuyama K, Kameoka J, Okuda M, Hayashi N, Yamamoto M, Abe K. Two chronic myelogenous leukemia cell lines which represent different stages of erythroid differentiation. Br J Haematol 1994;85:653-662.
57. Ray MK, Datta B, Chakraborty A, Chattopadhyay A, Meza-Keuthen S, Gupta NK. The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc Natl Acad Sci USA 1992;89:539-543.
58. Chakraborty A, Saha D, Bose A, Chatterjee M, Gupta NK. Regulation of eIF-2 alpha-subunit phosphorylation in reticulocyte lysate. Biochemistry 1994;33:6700-6706.
59. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992;80:575-581.
60. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993;362:722-728.
61. Solomon WB, Lin C-H, Palma J, Gao XY, Wu S. Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene. J Biol Chem 1993;268:5089-5096.
62. Kotkow KJ, Orkin SH. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol Cell Biol 1995;15:4640-4647.
63. Nagai T, Igarashi K, Furuyama K, Fujita H, Hayashi N, Yamamoto M, Sassa S. Upregulation of the erythroid transcription factor, NF-E2, by DMSO and hemin: distinctive mechanisms. Blood 1995;86:676a(abstr).
64. Harigae H, Yamamoto M, Fujita H, Weinstock P, Sassa S. In vitro differentiation of ES cells lacking the erythroid-specific δ-amnolevulinate synthase gene. Blood 1995;86:496a(abstr).
65. Lathrop JT, Timko MP. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science 1993;259:522-525.
66. Chan RY, Seiser C, Schulman HM, Kuhn LC, Ponka P. Regulation of transferrin receptor mRNA expression. Distinct regulatory features in erythroid cells. Eur J Biochem 1994;220:683-692.
67. Norris PG, Elder GH, Hawk JL. Homozygous variegate porphyria: a case report. Br J Dermatol 1990;122: 253-257.
68. D'Alessandro Gandolfo L, Macri A, Biolcati G, Griso D, Phung L, Deybach JC, Da Silva V, Nordmann Y, Topi GC. Homozygous variegate porphyria: revision of a diagnostic error [letter]. Br J Dermatol 1991;124:211
69. Murphy GM, Hawk JL, Magnus IA, Barrett DF, Elder GH, Smith SG. Homozygous variegate porphyria: two similar cases in unrelated families. J R Soc Med 1986;79:361-363.
70. Hift RJ, Meissner PN, Todd G, Kirby P, Bilsland D, Collins P, Ferguson J, Moore MR. Homozygous variegate porphyria: an evolving clinical syndrome [published erratum appears in Postgrad Med J 1994;70(829):855]. [Review.] Postgrad Med J 1993;69: 781-786.
71. Sassa S. Heme biosynthesis in erythroid cells: the distinctive aspects of the regulatory mechanism. In: Goldwasser E. (ed). Regulation of Hemoglobin Biosynthesis. Harvard, MA: Elsevier/North Holland, 1983:359-383.